ArticleCell reports. Medicine2022

SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents.

Pablo Garcia-Valtanen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.